EMEA-000014-PIP01-07-M06

Key facts

Invented name
Invega
Active substance
  • paliperidone
  • paliperidone palmitate
Therapeutic area
Psychiatry
Decision number
P/154/2011
PIP number
EMEA-000014-PIP01-07-M06
Pharmaceutical form(s)
  • Prolonged-release tablet
  • Suspension for injection
Condition(s) / indication(s)
  • Schizoaffective disorder
  • Schizophrenia
Route(s) of administration
  • Oral use
  • Intramuscular use
Contact for public enquiries
Janssen-Cilag International NV
bbyl@gcpbe.jnj.com
Belgium
Phone: +32 14607172
Fax: +32 473839426
Decision type
PM: decision on the application for modification of an agreed PIP
Compliance procedure number
EMEA-C-000014-PIP01-07-M06
Compliance opinion date
14/02/2013
Compliance outcome
positive

Decision

How useful was this page?

Add your rating